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Abstract
Background: Trauma/retrieval patients are often in shock and hypothermic. Treatment of such
patients usually involves restoring their blood volume with transfusion of blood (stored at 2°C –
6°C) and/or crystalloids or colloids (stored at ambient temperature). Rapid infusion of these cold
fluids can worsen or even induce hypothermia in these patients. Warming of intravenous fluids at
accident sites has traditionally been difficult due to a lack of suitable portable fluid warmers that
are not dependent on mains electrical or battery power. If latent heat, the heat released when a
liquid solidifies (an inherently temperature limiting process) can warm intravenous fluids, portable
devices without a reliance on electrical energy could be used to reduce the incidence of
hypothermia in trauma patients.
Methods: Rapid infusion of red cells into patients was timed to sample typical clinical flow rates.
An approved dry heat blood warmer was compared with a prototype blood warmer using a
supercooled liquid latent heat storage material, to warm red cells whilst monitoring inlet and outlet
temperatures. To determine the effect of warming on red cell integrity compared to the normal
storage lesion of blood, extracellular concentrations of potassium, lactate dehydrogenase and
haemoglobin were measured in blood which had been warmed after storage at 2°C – 6°C for 1 to
42 days.
Results: A prototype latent heat fluid warmer consistently warmed red cells from approximately
4°C to approximately 35°C at typical clinical flow rates. Warming of stored blood with latent heat
did not affect red cell integrity more than the approved dry heat blood warmer.
Conclusion: Using latent heat as an energy source can satisfactorily warm cold blood or other
intravenous fluids to near body temperature, without any adverse affects.
Background
Victims of major trauma are considered to be at risk of
hypothermia which often results in deleterious effects
(including coagulopathy, cardiac arrhythmias, peripheral
vasoconstriction, metabolic acidosis, compensatory
increased oxygen requirements during rewarming, and
impaired immune response) leading to an associated
increased mortality and morbidity [1,2]. Up to 66% of
Published: 1 August 2007
BMC Emergency Medicine 2007, 7:8 doi:10.1186/1471-227X-7-8
Received: 6 February 2007
Accepted: 1 August 2007
This article is available from: http://www.biomedcentral.com/1471-227X/7/8
© 2007 McEwen and Roxby; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
Page 2 of 14
(page number not for citation purposes)
trauma patients are reported to be hypothermic at the
time of hospital admission [2]. Those patients with a core
temperature lower than 34°C suffer a mortality rate up to
35% higher than euthermic patients [3-6].
At trauma sites it is common to transfuse red cells that
have been stored and transported at 4°C and/or colloid/
crystalloid fluids at ambient temperature. This adminis-
tration of cold intravenous fluids has been identified as
one of the main factors that contribute to the high inci-
dence of hypothermia in the trauma population [1].
To prevent falls of temperature, in hospitals there are sev-
eral mains powered devices available for warming fluids
before infusion into patients. However at retrieval or acci-
dent sites electrical energy is generally only available in
the form of batteries.
An alternative method of portable energy storage is in the
form of latent heat in supercooled liquids. A liquid is
supercooled when it remains in the liquid state at temper-
atures below its nominal solidification temperature.
Many substances can exist as supercooled liquids, eg
sodium acetate trihydrate (used in "heat packs") normally
freezes at approximately 55°C, but can remain in the liq-
uid state at temperatures below 10°C if it is kept free from
impurities in a sealed container. When a supercooled liq-
uid solidifies, it releases the latent heat of solidification
and its temperature quickly approaches the nominal
solidification temperature of the substance. This provides
an ideal situation for warming intravenous fluids, provid-
ing the desired warming temperature corresponds to the
solidification temperature of a latent heat storage mate-
rial.
A fluid warmer based on latent heat could be a relatively
simple and low-cost device. In its most basic form it may
consist of some latent heat storage material, some IV tub-
ing and an external casing.
This work aimed to determine if latent heat can be used to
warm blood from its storage temperature (2°C – 6°C) to
normal body temperature, this article describes the devel-
opment of a latent heat fluid warmer and its in vitro test-
ing.
Methods
Prototype construction
Prototype fluid warmers, consisting of (Gambro) infusion
extension lines immersed in a latent heat storage material,
with flexible or rigid external casings, were constructed.
The latent heat storage material had a phase change tem-
perature of 42°C, and was kept free from impurities to
enable it to be supercooled. The prototype used to warm
blood contained 0.85 litres of latent heat storage material.
Red cell units
Fresh red cells (RC) stored in Optisol®, that were unsuita-
ble for transfusion because they did not meet pre-deter-
mined criteria (such as the donor had visited a malarial
risk area within the previous 4 months), were supplied by
the Australian Red Cross Blood Service for in vitro tests.
All these RC units were marked "Component for discard".
These RC had a shelf life of 42 days from the day of collec-
tion and were kept under standard storage conditions
(2°C – 6°C) in validated temperature monitored cold
rooms until used for testing. The average volume of these
RC units was 275 mL. RC with a range of storage times (1
to 42 days) were tested in the latent heat fluid warmer.
Infusion flow rates
The infusion rate of red cells under normal clinical condi-
tions (not warmed with latent heat) was sampled by tim-
ing infusions into patients in the Intensive and Critical
Care Unit of Flinders Medical Centre. Red cells were deliv-
ered intravenously via 14, 16 or 20 gauge needles inserted
into the patient's right cubital fossa or right hand, whilst
being pressurised at 250 mmHg. All decisions affecting
patient care (choice of needle gauge, insertion site, infu-
sion pressure etc) were made by the staff of the Intensive
and Critical Care Unit, and the investigators were merely
observers.
Latent heat prototype testing
Latent heat was used to warm 67 units of RC in 25 tests;
12 tests were conducted using 1 unit of RC, 11 tests were
conducted using 4-units of RC, one test was conducted
using 5 units of RC and the final test was conducted using
6-units of RC. RC were gently massaged by hand prior to
testing, to mix the cells with clear fluid that had separated
during storage.
For each test 1, 4, 5 or 6 units of RC were surrounded by
Australian Red Cross Blood Service validated insulated
frozen coolant packs in a polystyrene box (<6°C), as
shown in figure 1. K-type thermocouples, connected to a
temperature logger, were placed in the fluid warmer inlet
and outlet ports, in the polystyrene box and in the latent
heat storage material inside the fluid warmer. Three-way
stopcocks were placed immediately upstream from the
thermocouple in the fluid warmer inlet line and immedi-
ately downstream from the thermocouple in the fluid
warmer outlet line. A 220 mm insulated intravenous (IV)
line was connected from the inlet stopcock to one of the
RC units, which was placed inside a pressure cuff in the
polystyrene box (the pressure cuff was inflated as
required, to pressurise the RC units and express their con-
tents). A tube was connected from the fluid warmer outlet
to a waste bag on top of an electronic balance and the bal-
ance output was recorded at approximately 30-second
intervals, for determining the outlet flow rate. 10 mL sam-BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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Test apparatus, 4 units of RC surrounded by coolant packs in a polystyrene box Figure 1
Test apparatus, 4 units of RC surrounded by coolant packs in a polystyrene box. One RC unit placed in a pressure cuff (which 
was inflated as required, to express the contents of the RC unit) and connected via a 220 mm insulated IV line and 3-way stop-
cock to the inlet of the blood warmer. A tube was connected from the blood warmer outlet via a 3-way stopcock to a waste 
bag on top of an electronic balance and the balance output was recorded at approximately 30-second intervals – for determin-
ing the outlet flow rate. 10 mL samples were withdrawn from the inlet stopcock when the RC from the unit first began flowing 
into the blood warmer, and from the outlet stopcock at the point where the unit was estimated to be half full and as the RC 
unit emptied. As each RC unit emptied, it was removed from the IV line and replaced with a full one (until all RC units in the 
polystyrene box had been used). K-type thermocouples, connected to a temperature logger, were placed in the blood warmer 
inlet and outlet ports, in the polystyrene box and in the latent heat storage material inside the blood warmer. Three-way stop-
cocks were placed immediately upstream from the thermocouple in the blood warmer inlet line and immediately downstream 
from the thermocouple in the blood warmer outlet line.BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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ples were withdrawn from the inlet stopcock when the RC
from the unit first began flowing into the fluid warmer,
and from the outlet stopcock at the point where the unit
was estimated to be half full and as the RC unit emptied.
As each RC unit emptied, it was removed from the IV line
and replaced with a full one (until all RC units in the pol-
ystyrene box had been used).
A similar test protocol was used with a Cobe SpectraTh-
erm (Lakewood, CO) dry heat mains powered fluid
warmer (regulated drum temperature of 36.7°C). The dry
heat blood warmer was used to warm 6 units of RC, with
one unit being warmed in each test.
Biochemical testing
In addition to the RC samples withdrawn during fluid
warmer testing, 10 mL samples were extracted from 4 RC
units kept in storage (2°C – 6°C) for their lifetimes (42
days), on storage days 2, 3, 6, 8, 9, 10, 13, 16, 22, 30, 34,
37 and 42. These samples were centrifuged and superna-
tant extracted (as described below) while they were cold.
Plasma potassium (K), lactate dehydrogenase (LD) and
haemoglobin (Hb) levels were determined to assess red
cell damage and level of haemolysis occurring either dur-
ing normal storage conditions (2°C – 6°C) or following
warming through the approved dry heat blood warmer or
the prototype.
Table 1: Rapid infusion flow rates
Needle Gauge No of infusions Average flow rate (mL/min)
14 2 54
16 2 43
20 1 24
Latent heat warming 4 units of RC, temperatures & flow graphed against volume Figure 2
Latent heat warming 4 units of RC, temperatures & flow graphed against volume.BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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Latent heat warming 4 units of RC, temperatures & flow graphed against time Figure 3
Latent heat warming 4 units of RC, temperatures & flow graphed against time.
Latent heat warming 6 units of RC Figure 4
Latent heat warming 6 units of RC.BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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All samples were centrifuged at an accelerating force of
2050 g for 4 minutes, after which time 500 μL of superna-
tant was removed and analyte concentrations were deter-
mined:
Potassium (mmol/L) was measured with a Roche modu-
lar ISE1800 analyser.
Lactate dehydrogenase (units/L) and a serum index,
equivalent to haemoglobin concentration (mg/dl) were
determined with a Roche modular P800 analyser.
Results
Infusion flow rates
For the limited number of timed infusions (table 1) using
14 or 16 gauge needles and pressurised at 250 mmHg, the
average infusion rate was approximately 50 mL/minute.
The infusion rate of RC is highly dependent on factors
such as needle gauge (Poiseuille's law) and venous access
site, therefore in a particular infusion, the actual rate of
infusion may vary from the rates measured in this case.
Fluid warmer testing
Most of the RC warmed with latent heat were in batches
of 4 – as would occur if a retrieval patient required approx-
imately 1100 mL of RC. Figure 2 shows typical results for
thses tests, four RC units were warmed from an average
inlet temperature of 3°C to an average of 35°C at flow
rates of 30–60 mL/minute. Halting the flow for approxi-
mately 3 minutes, while empty units were replaced, pro-
vided an opportunity to determine the extent to which the
fluid warmer output was temperature regulated. Figure 3
shows the same test results as figure 2, graphed against
time instead of volume, demonstrating the limited extent
of temperature overshoot that occurred whilst fluid flow
through the prototype was halted; neither the RC nor the
latent heat storage material exceeded the phase change
temperature of 42°C.
The output of the latent heat prototype fluid warmer did
decrease over time (as the release of latent heat
decreased).
Six RC units were also warmed from approximately 4°C
to an average of 32°C (figure 4). The rapid decline in
latent heat storage material temperature at the end of this
test indicates that the maximum number of RC units that
can be realistically warmed from 4°C with 0.85 litres of
the latent heat storage material is 6.
The dry heat blood warmer (figure 5) warmed single units
of RC from an average 3°C to 33°C.
Biochemical testing
The normal lesion occurring in stored blood was quite
severe. In the four RC units kept in storage mean extracel-
lular potassium concentration (figure 6) increased from
approximately 7 to 55 mmol/L from storage day 2 to day
42, plasma haemoglobin (figure 7) increased from
approximately 70 to 1000 mg/dL and lactate dehydroge-
nase (figure 8) increased from approximately 30 to 360
units/l.
In some of the warmed RC units the lesion appears to be
much worse, as indicated in figures 9 and 10 where extra-
cellular haemoglobin concentration was well over 1000
mg/dL and lactate dehydrogenase was over 800 units/L in
some RC units before warming.
Table 2: Means and standard deviations of extracellular potassium, haemoglobin and lactate dehydrogenase concentrations in RC units 
warmed with latent heat (n = 28) or the dry heat blood warmer (n = 6) between day 7 & 25 of storage, with initial haemoglobin 
concentration between 70 & 700 mg/dL
Sample from inlet line (before 
warming)
Sample from outlet line (midway 
through RC unit)
Sample from outlet line (at RC unit 
end)
Latent heat Dry heat Latent heat Dry heat Latent heat Dry heat
Potassium 
(mmol/L)
Mean 29 30 29 30 30 32
Standard 
deviation
7.2 10 6.6 10 7.4 10
Haemoglobin 
(mg/dL)
Mean 267 328 275 367 349 398
Standard 
deviation
139 231 140 251 183 264
Lactate 
Dehydrogenase 
(units/L)
Mean 240 302 244 282 262 296
Standard 
deviation
120 148 124 109 127 119BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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Dry heat blood warmer warming 1 unit of RC Figure 5
Dry heat blood warmer warming 1 unit of RC.
Extracellular potassium (K) in 4 red cell units during storage Figure 6
Extracellular potassium (K) in 4 red cell units during storage.BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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Extracellular haemoglobin (Hb) in 4 red cell units during storage Figure 7
Extracellular haemoglobin (Hb) in 4 red cell units during storage. Result for unit B on day 8 appears to be an anom-
aly, so has not been included in mean or SD calculation.
Extracellular lactate dehydrogenase (LD) in 4 red cell units during storage Figure 8
Extracellular lactate dehydrogenase (LD) in 4 red cell units during storage.BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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Extracellular haemoglobin (Hb) in pre, mid & post warmed RC warmed with latent heat or the dry heat blood warmer (n = 67) Figure 9
Extracellular haemoglobin (Hb) in pre, mid & post warmed RC warmed with latent heat or the dry heat blood 
warmer (n = 67). LH pre = Latent heat prototype, sample extracted from inlet line (before warming). LH mid = Latent heat 
prototype, sample extracted from outlet line midway through RC unit (warmed). LH post = Latent heat prototype, sample 
extracted from outlet line at the end of the RC unit (warmed). DH pre = Dry heat blood warmer, sample extracted from inlet 
line (before warming). DH mid = Dry heat blood warmer, sample extracted from outlet line midway through RC unit 
(warmed). DH post = Dry heat blood warmer, sample extracted from outlet line at the end of the red RC (warmed).
Extracellular lactate dehydrogenase (LD) in pre, mid & post warmed RC warmed with latent heat or the dry heat blood  warmer (n = 67) Figure 10
Extracellular lactate dehydrogenase (LD) in pre, mid & post warmed RC warmed with latent heat or the dry 
heat blood warmer (n = 67). LH pre = Latent heat prototype, sample extracted from inlet line (before warming). LH mid = 
Latent heat prototype, sample extracted from outlet line midway through RC unit (warmed). LH post = Latent heat prototype, 
sample extracted from outlet line at the end of the RC unit (warmed). DH pre = Dry heat blood warmer, sample extracted 
from inlet line (before warming). DH mid = Dry heat blood warmer, sample extracted from outlet line midway through RC 
unit (warmed). DH post = Dry heat blood warmer, sample extracted from outlet line at the end of the red RC (warmed).BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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Extracellular potassium (K) in pre, mid & post warmed RC warmed with latent heat or the dry heat blood warmer (n = 67) Figure 11
Extracellular potassium (K) in pre, mid & post warmed RC warmed with latent heat or the dry heat blood 
warmer (n = 67). LH pre = Latent heat prototype, sample extracted from inlet line (before warming). LH mid = Latent heat 
prototype, sample extracted from outlet line midway through RC unit (warmed). LH post = Latent heat prototype, sample 
extracted from outlet line at the end of the RC unit (warmed). DH pre = Dry heat blood warmer, sample extracted from inlet 
line (before warming). DH mid = Dry heat blood warmer, sample extracted from outlet line midway through RC unit 
(warmed). DH post = Dry heat blood warmer, sample extracted from outlet line at the end of the red RC (warmed).
Extracellular potassium (K) in the subset of pre, mid & post warmed RC (tested between day 7 & 25 of storage, with initial hae- moglobin concentration between 70 & 700 mg/dL) warmed with latent heat (n = 28) or the dry heat blood warmer (n = 6) Figure 12
Extracellular potassium (K) in the subset of pre, mid & post warmed RC (tested between day 7 & 25 of stor-
age, with initial haemoglobin concentration between 70 & 700 mg/dL) warmed with latent heat (n = 28) or the 
dry heat blood warmer (n = 6). LH pre = Latent heat prototype, sample extracted from inlet line (before warming). LH mid 
= Latent heat prototype, sample extracted from outlet line midway through RC unit (warmed). LH post = Latent heat proto-
type, sample extracted from outlet line at the end of the RC unit (warmed). DH pre = Dry heat blood warmer, sample 
extracted from inlet line (before warming). DH mid = Dry heat blood warmer, sample extracted from outlet line midway 
through RC unit (warmed). DH post = Dry heat blood warmer, sample extracted from outlet line at the end of the red RC 
(warmed).BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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Extracellular haemoglobin (Hb) in the subset of pre, mid & post warmed RC (tested between day 7 & 25 of storage, with initial  haemoglobin concentration between 70 & 700 mg/dL) warmed with latent heat (n = 28) or the dry heat blood warmer (n = 6) Figure 13
Extracellular haemoglobin (Hb) in the subset of pre, mid & post warmed RC (tested between day 7 & 25 of 
storage, with initial haemoglobin concentration between 70 & 700 mg/dL) warmed with latent heat (n = 28) or 
the dry heat blood warmer (n = 6). LH pre = Latent heat prototype, sample extracted from inlet line (before warming). 
LH mid = Latent heat prototype, sample extracted from outlet line midway through RC unit (warmed). LH post = Latent heat 
prototype, sample extracted from outlet line at the end of the RC unit (warmed). DH pre = Dry heat blood warmer, sample 
extracted from inlet line (before warming). DH mid = Dry heat blood warmer, sample extracted from outlet line midway 
through RC unit (warmed). DH post = Dry heat blood warmer, sample extracted from outlet line at the end of the red RC 
(warmed).
Extracellular haemoglobin (Hb) in the subset of pre, mid & post warmed RC (tested between day 7 & 25 of storage, with initial  haemoglobin concentration between 70 & 700 mg/dL) warmed with latent heat (n = 28) or the dry heat blood warmer (n = 6) Figure 13
Extracellular haemoglobin (Hb) in the subset of pre, mid & post warmed RC (tested between day 7 & 25 of 
storage, with initial haemoglobin concentration between 70 & 700 mg/dL) warmed with latent heat (n = 28) or 
the dry heat blood warmer (n = 6). LH pre = Latent heat prototype, sample extracted from inlet line (before warming). 
LH mid = Latent heat prototype, sample extracted from outlet line midway through RC unit (warmed). LH post = Latent heat 
prototype, sample extracted from outlet line at the end of the RC unit (warmed). DH pre = Dry heat blood warmer, sample 
extracted from inlet line (before warming). DH mid = Dry heat blood warmer, sample extracted from outlet line midway 
through RC unit (warmed). DH post = Dry heat blood warmer, sample extracted from outlet line at the end of the red RC 
(warmed).BMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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Extracellular lactate dehydrogenase (LD) in the subset of pre, mid & post warmed RC (tested between day 7 & 25 of storage,  with initial haemoglobin concentration between 70 & 700 mg/dL) warmed with latent heat (n = 28) or the dry heat blood  warmer (n = 6) Figure 14
Extracellular lactate dehydrogenase (LD) in the subset of pre, mid & post warmed RC (tested between day 7 & 
25 of storage, with initial haemoglobin concentration between 70 & 700 mg/dL) warmed with latent heat (n = 
28) or the dry heat blood warmer (n = 6). LH pre = Latent heat prototype, sample extracted from inlet line (before 
warming). LH mid = Latent heat prototype, sample extracted from outlet line midway through RC unit (warmed). LH post = 
Latent heat prototype, sample extracted from outlet line at the end of the RC unit (warmed). DH pre = Dry heat blood 
warmer, sample extracted from inlet line (before warming). DH mid = Dry heat blood warmer, sample extracted from outlet 
line midway through RC unit (warmed). DH post = Dry heat blood warmer, sample extracted from outlet line at the end of 
the red RC (warmed).
It was found that there was usually considerable superna-
tant in RC samples extracted before warming, and there
was much less supernatant in samples extracted from the
outlet mid way through RC units and even less superna-
tant in samples extracted from the outlet at the end of RC
units. This was probably an indication that cells had set-
tled towards the bottom of RC units, so the first portion
expressed from RC units was the leanest in cells and the
last portion expressed was the richest in cells.
Measurements of extracellular potassium (figures 6 and
11) were very similar in stored and warmed units of red
cells. Plasma haemoglobin (figures 7 and 9) and lactate
dehydrogenase (figures 8 and 10) exhibited larger varia-
tions in the 67 warmed units of RC than in the 4 units of
RC that remained in storage. This large spread of results
was evident in the "pre" samples extracted before warm-
ing as well as the "mid" and post" samples extracted after
warming (figures 9 and 10) indicating that most of the
variation in haemoglobin and lactate dehydrogenase
concentration was due to factors other than warming of
the RC units.
The six units of RC warmed with the dry heat blood
warmer were aged between 7 and 25 days and had extra-
cellular haemoglobin concentrations between 70 and
700 mg/dL before warming. To compare the effect of
warming RC with latent heat and the dry heat blood
warmer, a subset of the results from figures 9 to 11 was
used. This subset consisted of all the biochemical test
results obtained for RC units warmed between days 7 and
25 of storage and with extracellular haemoglobin concen-
trations between 70 and 700 mg/dL, before warming. The
subset included 28 RC units warmed with latent heat as
well as the 6 RC units warmed with the dry heat blood
warmer. Figures 12 to 14 show the biochemical test
results for this subset, and indicate that changes in extra-
cellular potassium, haemoglobin and lactate dehydroge-
nase concentrations during RC warming were similar for
both the latent heat prototype and dry heat blood warm-
ers.
The means and standard deviations of extracellular potas-
sium, haemoglobin and lactate dehydrogenase concen-
trations in this subset (table 2) indicate that the
concentrations of all analytes generally increased in RC
after warming, but the increase is similar for both meth-
ods of warming employed here.
Discussion
Flow rates of ambient temperature saline (pressurised at
300 mmHg) through IV delivery systems, including a
fluid warmer and 14 gauge cannula have been found to
be between 225 and 446 mL/minute, depending uponBMC Emergency Medicine 2007, 7:8 http://www.biomedcentral.com/1471-227X/7/8
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the type of fluid warmer used [7]. The flow rates sampled
in the present study in actual clinical situations were sig-
nificantly lower. Reasons for the lower flow rate in the
present study include: 250 mmHg used instead of 300
mmHg, the viscosity of blood is much higher than that of
saline and flow restrictions due to venous access sites.
Red cells have previously been heated to 44.7°C for 30
minutes with no damage reported [8], and it has also been
shown that incubation at 45°C for up to 1 hour does not
cause significant haemolysis [9]. Therefore damage due to
heating red cells to 42°C with the latent heat storage
material in the present study was not expected. Since
latent heat is only released at or below the solidification
temperature there could be no possibility of overheating
due to using the latent heat of solidification as an energy
source for warming blood.
Plasma potassium, lactate dehydrogenase and haemo-
globin were used in this study to indicate RC damage,
because they have previously been shown to be accurate
markers of haemolysis [10].
In general extracellular concentrations of these analytes
were higher in samples after warming than before warm-
ing in the present study. This may indicate damage as a
result of warming, but could also be a function of sam-
pling. As the amount of supernatant was greatest in the
first (unwarmed) samples and least in the last (warmed)
samples from RC units, the amount of cells in extracted
samples was least in the first samples and greatest in the
last samples from the RC units. The amount of extracellu-
lar potassium, haemoglobin and lactate dehydrogenase
could be expected to be related to the amount of cells in
the samples. Therefore the concentration of these analytes
could be expected to be lowest in the first ("pre") samples
extracted from RC units and highest in the last ("post")
samples extracted from RC units whether units were
warmed or not.
Although there was considerable variation in RC units
before warming in this study, when the biochemical test
results for units of similar age and initial condition were
compared for the latent heat prototype and the dry heat
blood warmer similar results were obtained for both
warming methods. Overall the results of the biochemical
tests for the latent heat fluid warmer, showed no signs of
increased cellular damage compared to red cells passed
through the clinically approved dry heat blood warmer.
It should be noted that the severity of the storage lesion of
blood found in this study may not be an indication of typ-
ical storage lesion, because the RC units used in this study
had been declared unsuitable for transfusion.
The further development of the use of latent heat as a
blood warming modality will depend upon the willing-
ness of medical device manufacturers to explore this field.
Conclusion
The feasibility of warming blood and other intravenous
fluids with a latent heat storage material has been demon-
strated. A low-cost portable non-electrically powered fluid
warmer using latent heat storage may be used to signifi-
cantly warm cold blood or intravenous fluids to near body
temperature with minimal risk of cellular damage and
haemolysis.
The big advantage of warming IV fluids using the latent
heat of fusion of a solidifying liquid is that heat is released
at the solidification temperature, which is inherently tem-
perature limiting. Consequently the risk of overheating
fluids with a latent heat IV fluid warmer is negligible. Test-
ing reported in this paper found that the warm blood out-
let temperature from a latent heat fluid warmer did not
exceed the phase change temperature of the latent heat
storage material, even during times of flow cessation.
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